Search

Your search keyword '"Sica, R. Alejandro"' showing total 314 results
Start Over Author "Sica, R. Alejandro"
314 results on '"Sica, R. Alejandro"'

3. Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis

Author

Wang, Trent P., Ahn, Kwang W., Shadman, Mazyar, Kaur, Manmeet, Ahmed, Nausheen, Bacher, Ulrike, Cerny, Jan, Chen, Andy, Epperla, Narendranath, Frigault, Matthew, Grover, Natalie, Haverkos, Bradley, Hill, Brian, Hossain, Nasheed, Iqbal, Madiha, Jain, Tania, Krem, Maxwell M., Maakaron, Joseph, Modi, Dipenkumar, Alhaj Moustafa, Muhamad, Riedell, Peter, Savani, Bipin, Sica, R. Alejandro, Sureda, Anna, Wudhikarn, Kitsada, Herrera, Alex F., Sauter, Craig, Hamadani, Mehdi, and Jimenez Jimenez, Antonio

Published
2024
Full Text
View/download PDF

4. Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study

Author

Iyer, Swaminathan P, Sica, R Alejandro, Ho, P Joy, Prica, Anca, Zain, Jasmine, Foss, Francine M, Hu, Boyu, Beitinjaneh, Amer, Weng, Wen-Kai, Kim, Youn H, Khodadoust, Michael S, Huen, Auris O, Williams, Leah M, Ma, Anna, Huang, Elaine, Ganpule, Avanti, Nagar, Shashwat Deepali, Sripakdeevong, Parin, Cullingford, Erika L, Karnik, Sushant, Dequeant, Mary-Lee, Patel, Janki N, He, Xinyi Shirley, Li, Ziliang, He, Qiuling Ally, Mendonez, Joy H, Keegan, Alissa, and Horwitz, Steven M

Published
2025
Full Text
View/download PDF

5. Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a CCC19 registry analysisImpact of B-cell malignancy therapy on COVID-19 outcomes

Author

Rubinstein, Samuel M, Bhutani, Divaya, Lynch, Ryan C, Hsu, Chih-Yuan, Shyr, Yu, Advani, Shailesh, Mesa, Ruben A, Mishra, Sanjay, Mundt, Daniel P, Shah, Dimpy P, Sica, R Alejandro, Stockerl-Goldstein, Keith E, Stratton, Catherine, Weiss, Matthias, Beeghly-Fadiel, Alicia, Accordino, Melissa, Assouline, Sarit E, Awosika, Joy, Bakouny, Ziad, Bashir, Babar, Berg, Stephanie, Bilen, Mehmet Asim, Castellano, Cecilia A, Cogan, Jacob C, Kc, Devendra, Friese, Christopher R, Gupta, Shilpa, Hausrath, Daniel, Hwang, Clara, Johnson, Nathalie A, Joshi, Monika, Kasi, Anup, Klein, Elizabeth J, Koshkin, Vadim S, Kuderer, Nicole M, Kwon, Daniel H, Labaki, Chris, Latif, Tahir, Lau, Eric, Li, Xuanyi, Lyman, Gary H, McKay, Rana R, Nagaraj, Gayathri, Nizam, Amanda, Nonato, Taylor K, Olszewski, Adam J, Polimera, Hyma V, Portuguese, Andrew J, Puc, Matthew M, Razavi, Pedram, Rosovski, Rachel, Schmidt, Andrew, Shah, Sumit A, Shastri, Aditi, Su, Christopher, Torka, Pallawi, Wise-Draper, Trisha M, Zubiri, Leyre, Warner, Jeremy L, and Thompson, Michael A

Subjects
Rare Diseases, Clinical Research, Prevention, Cancer, Aetiology, 2.1 Biological and endogenous factors, COVID-19, COVID-19 Testing, Humans, Lymphatic Diseases, Neoplasms, Risk Factors, SARS-CoV-2, COVID-19 and Cancer Consortium
Abstract

Patients with B-lymphoid malignancies have been consistently identified as a population at high risk of severe COVID-19. Whether this is exclusively due to cancer-related deficits in humoral and cellular immunity, or whether risk of severe COVID-19 is increased by anticancer therapy, is uncertain. Using data derived from the COVID-19 and Cancer Consortium (CCC19), we show that patients treated for B-lymphoid malignancies have an increased risk of severe COVID-19 compared with control populations of patients with non-B-lymphoid malignancies. Among patients with B-lymphoid malignancies, those who received anticancer therapy within 12 months of COVID-19 diagnosis experienced increased COVID-19 severity compared with patients with non-recently treated B-lymphoid malignancies, after adjustment for cancer status and several other prognostic factors. Our findings suggest that patients recently treated for a B-lymphoid malignancy are at uniquely high risk for severe COVID-19.SignificanceOur study suggests that recent therapy for a B-lymphoid malignancy is an independent risk factor for COVID-19 severity. These findings provide rationale to develop mitigation strategies targeted at the uniquely high-risk population of patients with recently treated B-lymphoid malignancies. This article is highlighted in the In This Issue feature, p. 171.

Published
2022

6. Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency

Author

Aminov, Sarah, Giricz, Orsi, Melnekoff, David T., Sica, R. Alejandro, Polishchuk, Veronika, Papazoglu, Cristian, Yates, Bonnie, Wang, Hao-Wei, Sahu, Srabani, Wang, Yanhua, Gordon-Mitchell, Shanisha, Leshchenko, Violetta V., Schinke, Carolina, Pradhan, Kith, Aluri, Srinivas, Sohn, Moah, Barta, Stefan K., Agarwal, Beamon, Goldfinger, Mendel, Mantzaris, Ioannis, Shastri, Aditi, Matsui, William, Steidl, Ulrich, Brody, Joshua D., Shah, Nirali N., Parekh, Samir, and Verma, Amit

Subjects
United States. National Cancer Institute, Chromatin, T cells, RNA sequencing, Viral antibodies, Immunotherapy, Ethylenediaminetetraacetic acid, B cells, Acute lymphocytic leukemia -- Drug therapy -- Development and progression, Genetic transcription, Antibodies, Health care industry
Abstract

While therapies targeting CD19 by antibodies, chimeric antigen receptor T cells (CAR-T), and T cell engagers have improved the response rates in B cell malignancies, the emergence of resistant cell populations with low CD19 expression can lead to relapsed disease. We developed an in vitro model of adaptive resistance facilitated by chronic exposure of leukemia cells to a CD19 immunotoxin. Single-cell RNA-Seq (scRNA- Seq) showed an increase in transcriptionally distinct [CD19.sup.lo] populations among resistant cells. Mass cytometry demonstrated that CD22 was also decreased in these [CD19.sup.lo]-resistant cells. An assay for transposase- accessible chromatin with sequencing (ATAC-Seq) showed decreased chromatin accessibility at promoters of both CD19 and CD22 in the resistant cell populations. Combined loss of both CD19 and CD22 antigens was validated in samples from pediatric and young adult patients with B cell acute lymphoblastic leukemia (B-ALL) that relapsed after CD19 CAR-T-targeted therapy. Functionally, resistant cells were characterized by slower growth and lower basal levels of MEK activation. [CD19.sup.lo] resistant cells exhibited preserved B cell receptor signaling and were more sensitive to both Bruton's tyrosine kinase (BTK) and MEK inhibition. These data demonstrate that resistance to CD19 immunotherapies can result in decreased expression of both CD19 and CD22 and can result in dependency on BTK pathways., Introduction Although much progress has been made in the treatment of B cell acute lymphoblastic leukemia (B-ALL), relapsed and refractory disease is an ongoing problem. The development of CD19 chimeric [...]

Published
2024
Full Text
View/download PDF

7. Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy study.

Author

Multani, Ashrit, Allard, Libby S, Wangjam, Tamna, Sica, R Alejandro, Epstein, David J, Rezvani, Andrew R, and Ho, Dora Y

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Emerging Infectious Diseases, Transplantation, Clinical Research, Infectious Diseases, Vaccine Related, Infection, Good Health and Well Being, Aged, Autopsy, Communicable Diseases, Diagnostic Errors, Hematopoietic Stem Cell Transplantation, Humans, Immunohistochemistry, Male, Middle Aged, Missed Diagnosis, Mortality, Patient Outcome Assessment, Transplant Recipients, Transplantation, Autologous, Transplantation, Homologous, Cardiovascular medicine and haematology
Abstract

Hematopoietic cell transplantation (HCT) is potentially curative for patients with hematologic disorders, but carries significant risks of infection-related morbidity and mortality. Infectious diseases are the second most common cause of death in HCT recipients, surpassed only by progression of underlying disease. Many infectious diseases are difficult to diagnose and treat, and may only be first identified by autopsy. However, autopsy rates are decreasing despite their value. The clinical and autopsy records of adult HCT recipients at our center who underwent autopsy between 1 January 2000 and 31 December 2017 were reviewed. Discrepancies between premortem clinical diagnoses and postmortem autopsy diagnoses were evaluated. Of 185 patients who underwent autopsy, 35 patients (18.8%) had a total of 41 missed infections. Five patients (2.7%) had >1 missed infection. Of the 41 missed infections, 18 (43.9%) were viral, 16 (39.0%) were fungal, 5 (12.2%) were bacterial, and 2 (4.9%) were parasitic. According to the Goldman criteria, 31 discrepancies (75.6%) were class I, 5 (12.2%) were class II, 1 (2.4%) was class III, and 4 (9.8%) were class IV. Autopsies of HCT recipients frequently identify clinically significant infectious diseases that were not suspected premortem. Had these infections been suspected, a change in management might have improved patient survival in many of these cases. Autopsy is underutilized and should be performed regularly to help improve infection-related morbidity and mortality. Illustrative cases are presented and the lessons learned from them are also discussed.

Published
2019

8. Efficacy and safety of CAR-T cell therapy in minorities

Author

Thakkar, Astha, Abreu, Michelly, Pradhan, Kith, Sica, R. Alejandro, Shastri, Aditi, Kornblum, Noah, Shah, Nishi, Mantzaris, Ioannis, Gritsman, Kira, Feldman, Eric, Elkind, Richard, Green-Lorenzen, Susan, Verma, Amit, Braunschweig, Ira, and Goldfinger, Mendel

Published
2022
Full Text
View/download PDF

9. Whole-genome landscape of adult T-cell leukemia/lymphoma

Author

Kogure, Yasunori, Kameda, Takuro, Koya, Junji, Yoshimitsu, Makoto, Nosaka, Kisato, Yasunaga, Jun-ichirou, Imaizumi, Yoshitaka, Watanabe, Mizuki, Saito, Yuki, Ito, Yuta, McClure, Marni B., Tabata, Mariko, Shingaki, Sumito, Yoshifuji, Kota, Chiba, Kenichi, Okada, Ai, Kakiuchi, Nobuyuki, Nannya, Yasuhito, Kamiunten, Ayako, Tahira, Yuki, Akizuki, Keiichi, Sekine, Masaaki, Shide, Kotaro, Hidaka, Tomonori, Kubuki, Yoko, Kitanaka, Akira, Hidaka, Michihiro, Nakano, Nobuaki, Utsunomiya, Atae, Sica, R. Alejandro, Acuna-Villaorduna, Ana, Janakiram, Murali, Shah, Urvi, Ramos, Juan Carlos, Shibata, Tatsuhiro, Takeuchi, Kengo, Takaori-Kondo, Akifumi, Miyazaki, Yasushi, Matsuoka, Masao, Ishitsuka, Kenji, Shiraishi, Yuichi, Miyano, Satoru, Ogawa, Seishi, Ye, B. Hilda, Shimoda, Kazuya, and Kataoka, Keisuke

Published
2022
Full Text
View/download PDF

10. Seroconversion rates following COVID-19 vaccination among patients with cancer

Author

Thakkar, Astha, Gonzalez-Lugo, Jesus D., Goradia, Niyati, Gali, Radhika, Shapiro, Lauren C., Pradhan, Kith, Rahman, Shafia, Kim, So Yeon, Ko, Brian, Sica, R. Alejandro, Kornblum, Noah, Bachier-Rodriguez, Lizamarie, McCort, Margaret, Goel, Sanjay, Perez-Soler, Roman, Packer, Stuart, Sparano, Joseph, Gartrell, Benjamin, Makower, Della, Goldstein, Yitz D., Wolgast, Lucia, Verma, Amit, and Halmos, Balazs

Published
2021
Full Text
View/download PDF

11. Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry Data

Author

Kaur, Gurbakhash, Mejia Saldarriaga, Mateo, Shah, Nishi, Catamero, Donna D., Yue, Lihua, Ashai, Nadia, Goradia, Niyati, Heisler, Joshua, Xiao, Zhengrui, Ghalib, Natasha, Aaron, Tonya, Cole, Daniel, Foreman, Rebecca, Mantzaris, Ioannis, Derman, Olga, Bachier, Lizamarie, Sica, R. Alejandro, Kornblum, Noah, Braunschweig, Ira, Shastri, Aditi, Goel, Sanjay, Verma, Amit, and Janakiram, Murali

Published
2021
Full Text
View/download PDF

15. A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohort

Author

Goldfinger, Mendel, Mantzaris, Ioannis, Shastri, Aditi, Saunthararajah, Yogen, Gritsman, Kira, Sica, R. Alejandro, Kornblum, Noah, Shah, Nishi, Levitz, David, Rockwell, Bradley, Shapiro, Lauren C., Gupta, Ridhi, Pradhan, Kith, Xue, Xiaonan, Munoz, Anne, Dhawan, Aradhika, Fehn, Karen, Comas, Monica, Verceles, Jhannine Alyssa, Jonas, Brian A., Kambhampati, Suman, Shi, Yang, Braunschweig, Ira, Cooper, Dennis L., Konopleva, Marina, Feldman, Eric J., and Verma, Amit

Published
2024
Full Text
View/download PDF

18. TCL-150 Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma

Author

Narvel, Hiba, Bazarbachi, Abdul-Hamid, Reef, Daniel, Patel, Riya, Thakkar, Astha, Zareef, Sumaira, de Castro, Alyssa, Mustafa, Jennat, Khatun, Fariha, Lombardo, Amanda, Gritsman, Kira, Goldfinger, Mendel, Wang, Yanhua, Kornblum, Noah, Shastri, Aditi, Mantzaris, Ioannis, Shah, Nishi, Braunschweig, Ira, Verma, Amit, Ye, Hilda, and Sica, R. Alejandro

Published
2022
Full Text
View/download PDF

19. ABCL-161 Reasons for Non-Referral for Autologous Stem Cell Transplantation in Central Nervous System Lymphoma (CNSL) Patients in a Minority-Rich, Multiracial, and Underprivileged Population at Montefiore Medical Center, Albert Einstein College of Medicine

Author

Narvel, Hiba, Yakkali, Shreyas, Bazarbachi, Abdul-hamid, Wang, Shuai, de Castro, Alyssa, Narvel, Adnan, Mustafa, Jennat, Khatun, Fariha, Lombardo, Amanda, Gritsman, Kira, Goldfinger, Mendel, Kornblum, Noah, Shastri, Aditi, Mcneill, Katharine, Janakiram, Murali, Mantzaris, Ioannis, Verma, Amit, Braunschweig, Ira, and Sica, R. Alejandro

Published
2022
Full Text
View/download PDF

20. POSTER: ALL-040 Hispanic Patients With T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Had Worse Overall Survival in a Minority Predominant Cohort

Author

Neupane, Karun, primary, Bazarbachi, Abdulhamed, additional, Dahal, Riyasha, additional, Reef, Daniel, additional, Shi, Yang, additional, Wang, Yanhua, additional, Gritsman, Kira, additional, Feldman, Eric, additional, Goldfinger, Mendel, additional, Kornblum, Noah, additional, Shastri, Aditi, additional, Mantzaris, Ioannis, additional, Shah, Nishi, additional, Cooper, Dennis, additional, Verma, Amit, additional, Ye, Bin Hilda, additional, Konopleva, Marina, additional, and Sica, R. Alejandro, additional

Published
2023
Full Text
View/download PDF

21. POSTER: MM-413 Early Mortality in Multiple Myeloma- a SEER Data Analysis

Author

Wei, John, primary, Shastri, Aditi, additional, Sica, R. Alejandro, additional, Mantzaris, Ioannis, additional, Kornblum, Noah, additional, Shah, Urvi, additional, Janakiram, Murali, additional, Gritsman, Kira, additional, Verma, Amit, additional, Goldfinger, Mendel, additional, Cooper, Dennis, additional, and Shah, Nishi, additional

Published
2023
Full Text
View/download PDF

22. ALL-040 Hispanic Patients With T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Had Worse Overall Survival in a Minority Predominant Cohort

Author

Neupane, Karun, primary, Bazarbachi, Abdulhamed, additional, Dahal, Riyasha, additional, Reef, Daniel, additional, Shi, Yang, additional, Wang, Yanhua, additional, Gritsman, Kira, additional, Feldman, Eric, additional, Goldfinger, Mendel, additional, Kornblum, Noah, additional, Shastri, Aditi, additional, Mantzaris, Ioannis, additional, Shah, Nishi, additional, Cooper, Dennis, additional, Verma, Amit, additional, Ye, Bin Hilda, additional, Konopleva, Marina, additional, and Sica, R. Alejandro, additional

Published
2023
Full Text
View/download PDF

23. MM-413 Early Mortality in Multiple Myeloma- a SEER Data Analysis

Author

Wei, John, primary, Shastri, Aditi, additional, Sica, R. Alejandro, additional, Mantzaris, Ioannis, additional, Kornblum, Noah, additional, Shah, Urvi, additional, Janakiram, Murali, additional, Gritsman, Kira, additional, Verma, Amit, additional, Goldfinger, Mendel, additional, Cooper, Dennis, additional, and Shah, Nishi, additional

Published
2023
Full Text
View/download PDF

24. Data from A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML

Author

Levitz, David, primary, Saunthararajah, Yogen, primary, Fedorov, Kateryna, primary, Shapiro, Lauren C., primary, Mantzaris, Ioannis, primary, Shastri, Aditi, primary, Kornblum, Noah, primary, Sica, R. Alejandro, primary, Shah, Nishi, primary, Konopleva, Marina, primary, Gritsman, Kira, primary, Braunschweig, Ira, primary, Cooper, Dennis L., primary, Pradhan, Kith, primary, Verma, Amit, primary, Feldman, Eric J., primary, and Goldfinger, Mendel, primary

Published
2023
Full Text
View/download PDF

25. Table S1 from A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML

Author

Levitz, David, primary, Saunthararajah, Yogen, primary, Fedorov, Kateryna, primary, Shapiro, Lauren C., primary, Mantzaris, Ioannis, primary, Shastri, Aditi, primary, Kornblum, Noah, primary, Sica, R. Alejandro, primary, Shah, Nishi, primary, Konopleva, Marina, primary, Gritsman, Kira, primary, Braunschweig, Ira, primary, Cooper, Dennis L., primary, Pradhan, Kith, primary, Verma, Amit, primary, Feldman, Eric J., primary, and Goldfinger, Mendel, primary

Published
2023
Full Text
View/download PDF

26. Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohort

Author

Narvel, Hiba, primary, Vegivinti, Charan, additional, Vikash, Sindhu, additional, Bazarbachi, Abdul Hamid, additional, Pradhan, Kith, additional, Wang, Shuai, additional, Hammami, M. Bakri, additional, Narvel, Nida, additional, Yakkali, Shreyas, additional, Ansari, Shehbaz, additional, Nabi, Adnan Gulam, additional, Mohammed, Turab, additional, Mantzaris, Ioannis, additional, Konopleva, Marina, additional, Goldfinger, Mendel, additional, Gritsman, Kira, additional, Cooper, Dennis, additional, Shastri, Aditi, additional, Shah, Nishi, additional, Kornblum, Noah, additional, Verma, Amit, additional, and Sica, R. Alejandro, additional

Published
2023
Full Text
View/download PDF

27. Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort

Author

Hammami, M. Bakri, Verceles, Jhannine Alyssa, Goldfinger, Mendel, Shah, Nishi, Sica, R. Alejandro, Mantzaris, Ioannis, Kornblum, Noah, Konopleva, Marina, Shastri, Aditi, Shapiro, Lauren C., Feldman, Eric J., Gritsman, Kira, Verma, Amit, and Cooper, Dennis L.

Abstract

•Racial disparities in donor availability limit access to HLA-matched HSCT.•The use of HLA-mismatched (5 to 7/8) unrelated donors may increase transplant access.•In an ethnically diverse cohort, all patients had ≥100 donors with 5 to 6/8 matches.•Expansion of the donor pool may allow prioritization of other donor factors.•Studies comparing mismatched versus other alternative donor transplants are required.

Published
2024
Full Text
View/download PDF

28. Lack of impact of umbilical cord blood unit processing techniques on clinical outcomes in adult double cord blood transplant recipients

Author

Nikiforow, Sarah, Li, Shuli, Snow, Karen, Liney, Deborah, Kao, Grace Shih-Hui, Haspel, Richard, Shpall, Elizabeth J., Glotzbecker, Brett, Sica, R. Alejandro, Armand, Philippe, Koreth, John, Ho, Vincent T., Alyea, Edwin P., III, Ritz, Jerome, Soiffer, Robert J., Antin, Joseph H., Dey, Bimal, McAfee, Steven, Chen, Yi-Bin, Spitzer, Thomas, Avigan, David, Cutler, Corey S., and Ballen, Karen

Published
2017
Full Text
View/download PDF

29. Clinicopathologic characterization of cutaneous adult T-cell leukemia/lymphoma: A single tertiary care center experience in the United States.

Author

Modi, Mitul B, Kiszluk, Alexandra, Chai, Jiani N, Edema, Ukuemi, Ma, Maxwell Y, Sica, R Alejandro, Wang, Yanhua, and Shi, Yang

Subjects
ADULT T-cell leukemia, HTLV, LIPS, T-cell receptor genes, LYMPHOMAS, BONE marrow, GENE rearrangement
Abstract

Objectives Adult T-cell leukemia/lymphoma (ATLL) is a rare aggressive T-cell leukemia/lymphoma associated with human T lymphotropic virus type 1 infection. The patients might present with skin rash before, at, or after the diagnosis. The dermatopathologic finding might be diagnostically very challenging. Methods We retrospectively identified 110 patients with ATLL at a single institution in a 19-year period, with 19 patients having skin biopsies. Clinical, dermatopathologic, immunophenotypic, and molecular findings were studied. Results The cohort included 13 skin-first (5 acute, 5 lymphomatous, 2 chronic, 1 smoldering), 6 skin-second (4 acute, 1 lymphomatous, 1 smoldering), and 91 patients without skin biopsy. Some nonphotoprotected areas of body such as the forearm and lower lip were also seen. Skin manifestations included papular (5), erythroderma (1), nodulotumoral (3), plaques (1), patches (1), and a combination of skin rashes (2). Histopathologic findings included large pleomorphic cells, angiocentrism, epidermal infiltration with large Pautrier-like microabscesses, and folliculotropism. Fifteen (78.9%) cases showed CD4+/CD7–/CD25+. Next-generation sequencing study was conducted on 5 patients using either blood or bone marrow samples, revealing multiple genetic mutations across multiple signaling pathways. Conclusions Pleomorphic large, atypical cells with CD4+/CD25+/CD7– immunophenotype from a non–"bathing trunk" location, especially in a patient from endemic regions, raise suspicion for ATLL. T-cell receptor gene rearrangement is almost always positive, and the neoplasm usually demonstrates multiple mutations by next-generation sequencing study. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

30. A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML

Author

Levitz, David, primary, Saunthararajah, Yogen, additional, Fedorov, Kateryna, additional, Shapiro, Lauren C., additional, Mantzaris, Ioannis, additional, Shastri, Aditi, additional, Kornblum, Noah, additional, Sica, R. Alejandro, additional, Shah, Nishi, additional, Konopleva, Marina, additional, Gritsman, Kira, additional, Braunschweig, Ira, additional, Cooper, Dennis L., additional, Pradhan, Kith, additional, Verma, Amit, additional, Feldman, Eric J., additional, and Goldfinger, Mendel, additional

Published
2023
Full Text
View/download PDF

31. Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis

Author

Abbasi, Ahmed, Peeke, Stephen, Shah, Nishi, Mustafa, Jennat, Khatun, Fariha, Lombardo, Amanda, Abreu, Michelly, Elkind, Richard, Fehn, Karen, de Castro, Alyssa, Wang, Yanhua, Derman, Olga, Nelson, Randin, Uehlinger, Joan, Gritsman, Kira, Sica, R. Alejandro, Kornblum, Noah, Mantzaris, Ioannis, Shastri, Aditi, Janakiram, Murali, Goldfinger, Mendel, Verma, Amit, Braunschweig, Ira, and Bachier-Rodriguez, Lizamarie

Published
2020
Full Text
View/download PDF

32. Supplementary Figure from Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19

Author

Rubinstein, Samuel M., primary, Bhutani, Divaya, primary, Lynch, Ryan C., primary, Hsu, Chih-Yuan, primary, Shyr, Yu, primary, Advani, Shailesh, primary, Mesa, Ruben A., primary, Mishra, Sanjay, primary, Mundt, Daniel P., primary, Shah, Dimpy P., primary, Sica, R. Alejandro, primary, Stockerl-Goldstein, Keith E., primary, Stratton, Catherine, primary, Weiss, Matthias, primary, Beeghly-Fadiel, Alicia, primary, Accordino, Melissa, primary, Assouline, Sarit E., primary, Awosika, Joy, primary, Bakouny, Ziad, primary, Bashir, Babar, primary, Berg, Stephanie, primary, Bilen, Mehmet Asim, primary, Castellano, Cecilia A., primary, Cogan, Jacob C., primary, KC, Devendra, primary, Friese, Christopher R., primary, Gupta, Shilpa, primary, Hausrath, Daniel, primary, Hwang, Clara, primary, Johnson, Nathalie A., primary, Joshi, Monika, primary, Kasi, Anup, primary, Klein, Elizabeth J., primary, Koshkin, Vadim S., primary, Kuderer, Nicole M., primary, Kwon, Daniel H., primary, Labaki, Chris, primary, Latif, Tahir, primary, Lau, Eric, primary, Li, Xuanyi, primary, Lyman, Gary H., primary, McKay, Rana R., primary, Nagaraj, Gayathri, primary, Nizam, Amanda, primary, Nonato, Taylor K., primary, Olszewski, Adam J., primary, Polimera, Hyma V., primary, Portuguese, Andrew J., primary, Puc, Matthew M., primary, Razavi, Pedram, primary, Rosovski, Rachel, primary, Schmidt, Andrew, primary, Shah, Sumit A., primary, Shastri, Aditi, primary, Su, Christopher, primary, Torka, Pallawi, primary, Wise-Draper, Trisha M., primary, Zubiri, Leyre, primary, Warner, Jeremy L., primary, and Thompson, Michael A., primary

Published
2023
Full Text
View/download PDF

33. Data from Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19

Author

Rubinstein, Samuel M., primary, Bhutani, Divaya, primary, Lynch, Ryan C., primary, Hsu, Chih-Yuan, primary, Shyr, Yu, primary, Advani, Shailesh, primary, Mesa, Ruben A., primary, Mishra, Sanjay, primary, Mundt, Daniel P., primary, Shah, Dimpy P., primary, Sica, R. Alejandro, primary, Stockerl-Goldstein, Keith E., primary, Stratton, Catherine, primary, Weiss, Matthias, primary, Beeghly-Fadiel, Alicia, primary, Accordino, Melissa, primary, Assouline, Sarit E., primary, Awosika, Joy, primary, Bakouny, Ziad, primary, Bashir, Babar, primary, Berg, Stephanie, primary, Bilen, Mehmet Asim, primary, Castellano, Cecilia A., primary, Cogan, Jacob C., primary, KC, Devendra, primary, Friese, Christopher R., primary, Gupta, Shilpa, primary, Hausrath, Daniel, primary, Hwang, Clara, primary, Johnson, Nathalie A., primary, Joshi, Monika, primary, Kasi, Anup, primary, Klein, Elizabeth J., primary, Koshkin, Vadim S., primary, Kuderer, Nicole M., primary, Kwon, Daniel H., primary, Labaki, Chris, primary, Latif, Tahir, primary, Lau, Eric, primary, Li, Xuanyi, primary, Lyman, Gary H., primary, McKay, Rana R., primary, Nagaraj, Gayathri, primary, Nizam, Amanda, primary, Nonato, Taylor K., primary, Olszewski, Adam J., primary, Polimera, Hyma V., primary, Portuguese, Andrew J., primary, Puc, Matthew M., primary, Razavi, Pedram, primary, Rosovski, Rachel, primary, Schmidt, Andrew, primary, Shah, Sumit A., primary, Shastri, Aditi, primary, Su, Christopher, primary, Torka, Pallawi, primary, Wise-Draper, Trisha M., primary, Zubiri, Leyre, primary, Warner, Jeremy L., primary, and Thompson, Michael A., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Tables S1-S5 from Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial

Author

Gonzalez-Lugo, Jesus D., primary, Kambhampati, Suman, primary, Yacoub, Abdulraheem, primary, Donnellan, William B., primary, Berdeja, Jesus, primary, Bhagat, Prafulla, primary, Fehn, Karen, primary, Remy, Cassady, primary, Jasra, Sakshi, primary, Kazemi, Mohammed, primary, Pradhan, Kith, primary, Kim, Mimi, primary, Mantzaris, Ioannis, primary, Sica, R. Alejandro, primary, Shah, Nishi, primary, Goldfinger, Mendel, primary, Kornblum, Noah, primary, Gritsman, Kira, primary, Braunschweig, Ira, primary, Steidl, Ulrich, primary, Will, Britta, primary, Shastri, Aditi, primary, and Verma, Amit, primary

Published
2023
Full Text
View/download PDF

35. Supplementary Figures S1-S2 from Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial

Author

Gonzalez-Lugo, Jesus D., primary, Kambhampati, Suman, primary, Yacoub, Abdulraheem, primary, Donnellan, William B., primary, Berdeja, Jesus, primary, Bhagat, Prafulla, primary, Fehn, Karen, primary, Remy, Cassady, primary, Jasra, Sakshi, primary, Kazemi, Mohammed, primary, Pradhan, Kith, primary, Kim, Mimi, primary, Mantzaris, Ioannis, primary, Sica, R. Alejandro, primary, Shah, Nishi, primary, Goldfinger, Mendel, primary, Kornblum, Noah, primary, Gritsman, Kira, primary, Braunschweig, Ira, primary, Steidl, Ulrich, primary, Will, Britta, primary, Shastri, Aditi, primary, and Verma, Amit, primary

Published
2023
Full Text
View/download PDF

36. Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents

Author

Spinner, Michael A, primary, Sica, R. Alejandro, additional, Tamaresis, John S, additional, Lu, Ying, additional, Chang, Cheryl, additional, Lowsky, Robert, additional, Frank, Matthew J., additional, Johnston, Laura J, additional, Miklos, David B, additional, Muffly, Lori, additional, Negrin, Robert S., additional, Rezvani, Andrew R., additional, Shiraz, Parveen, additional, Shizuru, Judith A., additional, Weng, Wen-Kai, additional, Binkley, Michael S., additional, Hoppe, Richard T., additional, Advani, Ranjana H, additional, and Arai, Sally, additional

Published
2023
Full Text
View/download PDF

37. A Co-Management Model For Myeloid Malignancies that Evolved During the COVID-19 Pandemic

Author

Goradia, Niyati, primary, Shastri, Aditi, additional, Verma, Amit, additional, Feldman, Eric, additional, Cooper, Dennis, additional, Konopleva, Marina, additional, Fox, Susan, additional, Gritsman, Kira, additional, Shah, Nishi, additional, Mantzaris, Ioannis, additional, Braunschweig, Ira, additional, Kornblum, Noah, additional, Sica, R Alejandro, additional, Levitz, David, additional, Comas, Monica, additional, and Goldfinger, Mendel, additional

Published
2022
Full Text
View/download PDF

38. A Non-Cytotoxic Regimen Using a Weekly Low Dose Decitabine and Venetoclax for MDS and AML in a Real World Cohort

Author

Levitz, David, primary, Fedorov, Kateryna, additional, Pradhan, Kith, additional, Shapiro, Lauren C, additional, Shastri, Aditi, additional, Gritsman, Kira, additional, Shah, Nishi, additional, Kornblum, Noah, additional, Sica, R. Alejandro, additional, Braunschweig, Ira, additional, Konopleva, Marina, additional, Feldman, Eric J., additional, Verma, Amit, additional, Mantzaris, Ioannis, additional, Saunthararajah, Yogenthiran, additional, and Goldfinger, Mendel, additional

Published
2022
Full Text
View/download PDF

39. Barriers to Autologous Stem Cell Transplantation As Consolidation for Primary Central Nervous System Lymphoma (PCNSL) in HIV Positive Patients in a Minority Rich Cohort in the Bronx, New York

Author

Narvel, Hiba, primary, Vikash, Sindhu, additional, Vegivinti, Charan Thej Reddy, additional, Bazarbachi, Abdul-Hamid, additional, Hammami, M Bakri, additional, Mehta, Ansh Krishnachandra, additional, Reef, Daniel K., additional, Narvel, Adnan, additional, Patel, Riya, additional, Shastri, Aditi, additional, Kornblum, Noah, additional, Mantzaris, Ioannis, additional, Konopleva, Marina, additional, Cooper, Dennis, additional, Shah, Nishi, additional, Goldfinger, Mendel, additional, Braunschweig, Ira, additional, Verma, Amit, additional, and Sica, R. Alejandro, additional

Published
2022
Full Text
View/download PDF

40. Resistance to CD19 Immunotherapy in B-Cell ALL Is Associated with Loss of CD19 and CD22 and an Enhanced Vulnerability to B Cell Receptor Signaling Inhibition

Author

Aminov, Sarah, primary, Giricz, Orsi, additional, Sica, R. Alejandro, additional, Polishchuk, Veronika, additional, Yates, Bonnie, additional, Wang, Hao-Wei, additional, Wang, Yanhua, additional, Sahu, Srabani, additional, Gordon, Shanisha, additional, Schinke, Carolina, additional, Pradhan, Kith, additional, Aluri, Srinivas, additional, Janakiram, Murali, additional, Barta, Stefan K., additional, Agarwal, Beamon, additional, Goldfinger, Mendel, additional, Shastri, Aditi, additional, Matsui, William, additional, Steidl, Ulrich, additional, Brody, Joshua, additional, Shah, Nirali N., additional, Parekh, Samir, additional, and Verma, Amit, additional

Published
2022
Full Text
View/download PDF

41. Outcomes of Autologous Stem Cell Transplantation for Relapsed DLBCL in Single Center Serving a Minority Population

Author

Jain, Tanim, primary, Bazarbachi, Abdul-Hamid, additional, Rabinovich, Emma, additional, Abbasi, Ahmed, additional, Pradhan, Kith, additional, Reef, Daniel K., additional, Quinn, Ryann, additional, Narvel, Hiba, additional, Patel, Riya, additional, Al Hamed, Rama, additional, Thakkar, Astha, additional, Rahman, Shafia, additional, De Castro, Alyssa, additional, Joseph, Felisha, additional, Gillick, Kailyn, additional, Mustafa, Jennat, additional, Khatun, Fariha, additional, Lombardo, Amanda, additional, Townsend Nugent, Latoya, additional, Abreu, Michelly, additional, Chambers, Nicole, additional, Elkind, Richard, additional, Shi, Yang, additional, Wang, Yanhua, additional, Derman, Olga, additional, Zang, Xingxing, additional, Gritsman, Kira, additional, Steidl, Ulrich G., additional, Goldfinger, Mendel, additional, McCort, Margaret, additional, Puius, Yoram, additional, Bartash, Rachel, additional, Kornblum, Noah, additional, Shastri, Aditi, additional, Mantzaris, Ioannis, additional, Bachier Rodriguez, Lizamarie, additional, Shah, Nishi, additional, Konopleva, Marina, additional, Nishimura, Christopher, additional, Cooper, Dennis, additional, Braunschweig, Ira, additional, Verma, Amit, additional, and Sica, R. Alejandro, additional

Published
2022
Full Text
View/download PDF

42. Outcomes Analysis of T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (T-ALL/T-LBL) in a Minority Rich Cohort

Author

Neupane, Karun, primary, Bazarbachi, Abdul-Hamid, additional, Reef, Daniel K., additional, Pradhan, Kith, additional, Narvel, Hiba, additional, De Castro, Alyssa, additional, Joseph, Felisha, additional, Gillick, Kailyn, additional, Khatun, Fariha, additional, Lombardo, Amanda, additional, Shi, Yang, additional, Wang, Yanhua, additional, Gritsman, Kira, additional, Steidl, Ulrich, additional, Goldfinger, Mendel, additional, Kornblum, Noah, additional, Shastri, Aditi, additional, Mantzaris, Ioannis, additional, Bachier Rodriguez, Lizamarie, additional, Shah, Nishi, additional, Cooper, Dennis, additional, Braunschweig, Ira, additional, Verma, Amit, additional, Ye, Bin Hilda, additional, Konopleva, Marina, additional, and Sica, R. Alejandro, additional

Published
2022
Full Text
View/download PDF

43. Adult T-Cell Leukemia/Lymphoma Diagnosed in North American Is Characterized By a Requirement for BCL6 and a Cell Cycle Program Associated with DNA Replication Stress

Author

Ye, B. Hilda, primary, Chung, Elaine, additional, Ren, Xiaoxin, additional, Pradhan, Kith, additional, Wang, Yanhua, additional, Madireddy, Advaitha, additional, Zang, Xingxing, additional, Janakiram, Murali, additional, Sica, R. Alejandro, additional, and Verma, Amit, additional

Published
2022
Full Text
View/download PDF

44. Trends in Collection and Utilization of Autologous Hematopoietic Stem Cells (APBHC) Intended for Transplant in Patients with Multiple Myeloma

Author

Samuel, Nina, primary, Laufer, Lauren, additional, Tanaguchi, Rodrigo, additional, Rosiene, Joel, additional, Palesi, Carlo, additional, Elkind, Richard, additional, Mantzaris, Ioannis, additional, Shastri, Aditi, additional, Kornblum, Noah, additional, Sica, R. Alejandro, additional, Shah, Urvi A, additional, Cooper, Dennis, additional, Verma, Amit, additional, and Shah, Nishi, additional

Published
2022
Full Text
View/download PDF

45. Oncogenic JAK2/STAT Signaling Molecules Activation Is Associated with PD-L1 Upregulation in Acute Myeloid Leukemia

Author

Chai, Jiani, primary, Choudhuri, Jui, additional, Wang, Qing, additional, Fang, Yanan, additional, Shi, Yang, additional, Shen, Wa, additional, Goel, Swati, additional, Mantzaris, Ioannis, additional, Shastri, Aditi, additional, Sica, R. Alejandro, additional, Shah, Nishi, additional, Gritsman, Kira, additional, Konopleva, Marina, additional, Kornblum, Noah, additional, Verma, Amit, additional, Goldfinger, Mendel, additional, Wang, Yanhua, additional, and Tian, Xuejun, additional

Published
2022
Full Text
View/download PDF

46. Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS: Assessment of Leukemia Stem Cell Eradication By High-Resolution MRD Assay

Author

Mantzaris, Ioannis, primary, Goldfinger, Mendel, additional, Levitz, David, additional, Fedorov, Kateryna, additional, Fehn, Karen, additional, Chambers, Nicole, additional, Munoz, Anne, additional, Dhawan, Aradhika, additional, Victor, Joel, additional, Shah, Nishi, additional, Shastri, Aditi, additional, Kornblum, Noah, additional, Sica, R. Alejandro, additional, Gritsman, Kira, additional, Cooper, Dennis, additional, Kim, Mimi, additional, Gavathiotis, Evripidis, additional, Konopleva, Marina, additional, Verma, Amit, additional, Feldman, Eric J., additional, and Steidl, Ulrich G., additional

Published
2022
Full Text
View/download PDF

47. Autologous Stem Cell Transplantation (ASCT) Improves Survival Outcome in Primary Central Nervous System Lymphoma (PCNSL) in a Minority Rich, Underserved Inner City Population in the Real-World Setting

Author

Narvel, Hiba, primary, Vegivinti, Charan Thej Reddy, additional, Vikash, Sindhu, additional, Bazarbachi, Abdul-Hamid, additional, Wang, Shuai, additional, Reef, Daniel K., additional, Hammami, M Bakri, additional, Narvel, Adnan, additional, Mehta, Ansh Krishnachandra, additional, Mantzaris, Ioannis, additional, Shah, Nishi, additional, Goldfinger, Mendel, additional, Kornblum, Noah, additional, Konopleva, Marina, additional, Shastri, Aditi, additional, Braunschweig, Ira, additional, Verma, Amit, additional, and Sica, R. Alejandro, additional

Published
2022
Full Text
View/download PDF

48. Factors Associated with Early Mortality in Patients with Multiple Myeloma: A SEER Analysis

Author

Wei, John X, primary, Sisto, Alex, additional, Shastri, Aditi, additional, Sica, R. Alejandro, additional, Mantzaris, Ioannis, additional, Kornblum, Noah, additional, Shah, Urvi A, additional, Janakiram, Murali, additional, Gritsman, Kira, additional, Verma, Amit, additional, Goldfinger, Mendel, additional, Cooper, Dennis, additional, and Shah, Nishi, additional

Published
2022
Full Text
View/download PDF

49. Allogeneic but Not Autologous Stem Cell Transplantation Improves Outcome in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma

Author

Bazarbachi, Abdul-Hamid, primary, Reef, Daniel K., additional, Narvel, Hiba, additional, Patel, Riya, additional, Al Hamed, Rama, additional, Thakkar, Astha, additional, Rahman, Shafia, additional, Shah, Urvi A, additional, Adrianzen Herrera, Diego, additional, Quinn, Ryann, additional, Zareef, Sumaira, additional, Rabinovich, Emma, additional, De Castro, Alyssa, additional, Joseph, Felisha, additional, Gillick, Kailyn, additional, Mustafa, Jennat, additional, Khatun, Fariha, additional, Lombardo, Amanda, additional, Townsend Nugent, Latoya, additional, Abreu, Michelly, additional, Chambers, Nicole, additional, Elkind, Richard, additional, Shi, Yang, additional, Wang, Yanhua, additional, Derman, Olga, additional, Gritsman, Kira, additional, Steidl, Ulrich, additional, Goldfinger, Mendel, additional, Kornblum, Noah, additional, Shastri, Aditi, additional, Mantzaris, Ioannis, additional, Bachier Rodriguez, Lizamarie, additional, Shah, Nishi, additional, Cooper, Dennis, additional, Braunschweig, Ira, additional, Verma, Amit, additional, Ye, B. Hilda, additional, Janakiram, Murali, additional, and Sica, R. Alejandro, additional

Published
2022
Full Text
View/download PDF

50. Pre-Conditioning Easix Is Associated with Survival after Autologous Hematopoietic Stem Cell Transplant in Mature T-Cell Lymphomas

Author

Reef, Daniel K., primary, Wei, John, additional, De Castro, Alyssa, additional, Joseph, Felisha, additional, Gillick, Kailyn, additional, Mustafa, Jennat, additional, Khatun, Fariha, additional, Lombardo, Amanda, additional, Townsend Nugent, Latoya, additional, Abreu, Michelly, additional, Chambers, Nicole, additional, Elkind, Richard, additional, Shi, Yang, additional, Wang, Yanhua, additional, Derman, Olga, additional, Gritsman, Kira, additional, Steidl, Ulrich G., additional, Goldfinger, Mendel, additional, Kornblum, Noah, additional, Shastri, Aditi, additional, Mantzaris, Ioannis, additional, Bachier-Rodriguez, Lizamarie, additional, Shah, Nishi, additional, Konopleva, Marina, additional, Cooper, Dennis, additional, Braunschweig, Ira, additional, Verma, Amit, additional, and Sica, R. Alejandro, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results